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Electrosensitization Increases Antitumor
Effectiveness of Nanosecond Pulsed Electric
Fields In Vivo
Claudia Muratori, PhD1, Andrei G. Pakhomov, PhD1, Loree Heller, PhD1,
Maura Casciola, PhD1, Elena Gianulis, PhD1, Sergey Grigoryev, PhD1,
Shu Xiao, PhD1, and O. N. Pakhomova, PhD1
Abstract
Nanosecond pulsed electric fields are emerging as a new modality for tissue and tumor ablation. We previously reported that cells
exposed to pulsed electric fields develop hypersensitivity to subsequent pulsed electric field applications. This phenomenon,
named electrosensitization, is evoked by splitting the pulsed electric field treatment in fractions (split-dose treatments) and causes
in vitro a 2- to 3-fold increase in cytotoxicity. The aim of this study was to show the benefit of split-dose treatments for in vivo
tumor ablation by nanosecond pulsed electric field. KLN 205 squamous carcinoma cells were embedded in an agarose gel or
grown subcutaneously as tumors in mice. Nanosecond pulsed electric field ablations were produced using a 2-needle probe with a
6.5-mm interelectrode distance. In agarose gel, splitting a pulsed electric field dose of 300, 300-ns pulses (20 Hz, 4.4-6.4 kV) in 2 equal
fractions increased cell death up to 3-fold compared to single-train treatments. We then compared the antitumor effectiveness of
these treatments in vivo. At 24 hours after treatment, sensitizing tumors by a split-dose pulsed electric field exposure (150 þ 150,
300-ns pulses, 20 Hz, 6.4 kV) caused a 4- and 2-fold tumor volume reduction as compared to sham and single-train treatments,
respectively. Tumor volume reduction that exceeds 75% was 43% for split-dose–treated animals compared to only 12% for single-
dose treatments. The difference between the 2 experimental groups remained statistically significant for at least 1 week after the
treatment. The results show that electrosensitization occurs in vivo and can be exploited to assist in vivo cancer ablation.
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nanosecond pulsed electric fields (nsPEF), irreversible electroporation, tumor ablation, nanoporation, electrosensitization
Abbreviations
DT, doubling time; EMEM, Eagle’s minimum essential medium; IRE, irreversible electroporation; nsPEF, nanosecond pulsed
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rate; ROI, region of interest; ROS, reactive oxygen species
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Introduction
Several local ablative therapies have been explored as innova-
tive treatments to fight cancer. The advantages of these proce-
dures include increased safety, less scarring, fast recovery, and
decreased length of hospital stay.1 Irreversible electroporation
(IRE) is a promising new minimally invasive technique for
tumor ablation. Irreversible electroporation uses high-
intensity pulsed electric fields (PEF) of 100 ms duration to
cause irreparable cell damage and destroy tissues.2 Compared
to other conventional ablation methods, such as radiofrequency
heating and cryoablation, IRE treatments preserve vital
structures and major blood vessels within the ablated zone.3
Irreversible electroporation was found particularly efficient at
treating tumors less than 3.0 cm.2 However, larger lesions
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require the repositioning of the electrodes, making the procedure
more complex. Because of this limitation, ongoing research
focuses on establishing well-defined treatment planning proto-
cols and improving the treatment delivery methods.4-6
Recently, IRE protocols have been extended to nanosecond
pulse durations. Nanosecond pulsed electric fields (nsPEF)
have been shown to cause complete regression of murine mel-
anoma with no recurrence.7-9 Nanosecond pulsed electric field
induced apoptosis in tumor cells and disrupted tumor’s blood
supply.8 Nanosecond pulsed electric field effects encompass
nanoporation of membranes (plasma membrane, endoplasmic
reticulum, and mitochondria),10-15 Ca2þ uptake from the out-
side and release from the endoplasmic reticulum,13,14,16,17
destruction of the cytoskeleton and cell blebbing,18-21 activa-
tion of signaling pathways,22-24 and induction of necrosis and
apoptosis.10,25-27 The diversity of these effects is promising for
future therapeutic applications of nsPEF.
We previously reported a gradual intensification in the
sensitivity of electroporated cells to incoming PEF treat-
ments, a phenomenon that has been named electrosensitiza-
tion.28 Since electrosensitization develops with time, this
phenomenon can be engaged by either using a single dose
of pulses delivered at a low pulse repetition rate (PRR) or
splitting a high PRR dose into fractions separated by a proper
latency time. Indeed, the PRR is one of the key factors that
determine the efficiency of electroporation, and many studies
have reported the higher efficiency of low PRR.28-34 Our
standard electrosensitization protocol consists in delivering
2 high-frequency trains of pulses separated by a proper inter-
val.28,35-37 Engaging electrosensitization increases the
cytoxic effect of a PEF treatment 2- to 3-fold and causes a
significant reduction in the PEF lethal dose.
Electrosensitization has also been shown to improve the
electroporative uptake of the cytostatic agent bleomycin.35 Bleo-
mycin is used in combination with PEF in electrochemotherapy
protocols.38-40 Electrosensitization profoundly increased the
electroporation-assisted bleomycin uptake and caused an
increase in lethality comparable to a 10-fold increase in
bleomycin concentration when using a single PEF dose.35
Recently, the increase in the ablation zone created by split-
dose protocols engaging electrosensitization has been visua-
lized in 3-dimensional (3D) cultures. In agarose-embedded
KLN 205 cells and matrigel spheroids, dose fractionation
increased the ablation volume and cell death up to 2- to 3-
fold compared to single-train treatments.37
To date, electrosensitization phenomenon has been reported
in vitro for PEF durations ranging from 60 ns to 100 ms and
pulse amplitudes from 1.8 to 13.3 kV/cm, in multiple cell lines
(CHO, B16, U937, Jurkat, and KLN 205), and for diverse
experimental settings (cells in suspension, substrate-attached
cells, cells embedded in agarose gel, or grown as spheroids
in matrigel).28,35-37
In this study, we compared the in vivo antitumor effi-
cacy of split- and single-dose nsPEF treatments. Engaging
electrosensitization caused increased tumor reduction showing
its benefit for tumor ablation in vivo.
Electrosensitization can potentially enable the use of lower
electric field amplitudes to achieve the same or better ablation
effect than standard single-train protocols. Attaining the ther-
apeutic effect at much lower exposure doses translates into a
reduction in the thermal damage due to the Joule heating and
could potentially minimize IRE known side effects such as
pain, muscle contraction, and cardiac arrhythmias when treat-
ments are done in the proximity of the heart.
Materials and Methods
Cell Line and Media
Experiments were performed using a mouse squamous cell
carcinoma KLN 205 cell line (ATCC, Manassas, Virginia).41
Cells were cultured in Eagle’s minimum essential medium with
L-glutamine (ATCC), supplemented with 10% (v/v) fetal
bovine serum (Atlanta Biologicals, Norcross, Georgia), 100
U/mL penicillin and 0.1 mg/mL streptomycin (Mediatech Cell-
gro, Herdon, Virginia).
Pulsed Electric Field Exposure
The same PEF exposure system was used for both 3D cultures
and tumors in mice.
Trapezoidal pulses of 300 ns duration were produced by a
custom pulse generation system with an output impedance of
100 Ω, adjustable pulse amplitude (up to 15 kV), duration
(150-2000 ns), and frequency (1-100 Hz; Tangers Electronics,
Norfolk, Virginia; Figure 1A). Pulsed electric field was deliv-
ered by a PEF-delivering 2-needle electrode probe made from
0.5 mm diameter hollow syringe needles. The edge-to-edge
distance between the needles was 6.5 mm with a maximum
penetration capacity in agarose culture or the mouse skin of 5
mm (Figure 1B). To produce pulse trains of predetermined
duration at selected repetition rates, the generator was triggered
externally from a model S8800 stimulator (Grass Instrument
Co, Quincy, Massachusetts). Pulse amplitude was monitored in
all experiments, using a 200 MHz, 1 GS/s DSO5202B digital
oscilloscope (Antek, Qingdao City, China). The shape of the
electric pulse at 6.4 kV is reported in Figure 1C.
Pulsed electric field delivery to cells embedded in agarose
gel was accomplished by mounting the electrodes on a micro-
manipulator to enable accurate and steady positioning of the
needles within the gel with cells in a 35-mm Petri dish. For
accurate comparison, different PEF treatments and sham expo-
sure (no pulses delivered) were performed in the same cell
sample for a maximum of 6 exposures per dish. We previously
reported that electrosensitization develops only if the electric
field is above the threshold for electroporation.42 In our experi-
ments, each exposure was spaced 1 cm from the previous one to
avoid any “electroporation-preconditioning” of the area. In
fact, for 300 ns pulses applied at 6.4 kV (which is the highest
electric field used in the in vitro experiments shown in
Figure 4), the electric field at 1 cm from the electrodes is
0.8 kV/cm. Based on the electroporation thresholds found, for
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200 and 600 ns pulses, which are 1.5 to 1.9 and 1 kV/cm,
respectively,43,44 0.8 kV/cm gives a good safety margin being
about 2-fold below the expected threshold for 300 ns pulses.
For tumor PEF treatments, mice were anesthetized by inha-
lation of 3% isoflurane in air (Patterson Veterinary, Devens,
Massachusetts). The 2-needle electrode was inserted at the
opposite margins of the tumor by lifting the overlying skin.
Ultrasound conductive gel (Parker Laboratories, Fairfield, New
Jersey) was used to ensure an efficient electrical continuity.
During PEF treatments, the probe was held by hand and read-
justed to the proper position between trains if needed. Animals
in the sham control group underwent anesthesia and the probe
insertion procedure but no PEF delivery. Tumors were sub-
jected to a single-PEF treatment with 1 electrode insertion.
Electric Field Simulation and Temperature
Measurements
To quantify the electric field distribution, we carried out a 3D
numerical simulations using the commercial finite element
method solver COMSOL Multiphysics, Release 5.0. Figure 2A
shows the electric field at the cell location between the electrodes,
3.8 mm above the plane of the Petri dish. The dish was modeled as
a 2-mm thick layer of polystyrene. To match the experimental
conditions, the electrodes (modeled as stainless steel) were posi-
tioned perpendicular to the Petri dish, 1 mm above it. The electric
currents interface was used to solve Maxwell equations under the
assumption of steady-state conditions, for which:
r  ðsrV Þ ¼ 0 ð1Þ
This equation is solved for the voltage field, V, which is used
to compute the electric field, E ¼ rV , and the current,
J ¼ sE, where s is the material conductivity.
Since, the calculations were based on an electrostatic model
that disregards the dispersive properties of the medium: this was
possible since the dielectric relaxation time for a buffer conduc-
tivity of 1.4 S/m would be on the order of few nanoseconds, much
shorter than the nsPEF duration considered.45-47 The tetrahedral
mesh chosen to discretize the domain of simulation (sphere of air
with radius of 21.8 mm) resulted in a total of 668 169 elements,
with a minimum size of 0.065 mm and a maximum size of 1.530
mm. Quadratic elements were used throughout the solution
domain, giving 0.9  106 degrees of freedom. Under these con-
ditions, the mean electric field and its standard deviation (SD) in
the region of interest (ROI), defined as a 1 mm  1 mm square
between the electrodes, was 0.082 (0.001) kV/cm for 100 V of
input. The coefficient of variation in percent, namely the ratio of
Figure 1. Pulsed electric field (PEF) exposure system. A, The pulse generator (1) was triggered externally from a stimulator (2), and the pulse
amplitude and shape were monitored using a digital oscilloscope (3). B, The 2-needle probe showing the 6.5 mm separation. C, The shape of the
electric pulse at 6.4 kV.
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the SD over the mean value of the electric field, was 1.2% show-
ing the high homogeneity of the electric field in the ROI.
In the 3D cultures, the local heating was measured using a fiber
optic ReFlex-4 thermometer (Nortech Fibronic, Quebec City,
Canada). The fiber optic probe was inserted into the agarose cul-
ture in the centerof the gap between the electrodes (Figure 2B). By
the end of PEF exposure, the measured values for 300, 300-ns
pulses at 4.4, 5.4, and 6.4 kV delivered at 20 Hz averaged 0.5, 0.8,
and 1.1C, respectively (Figure 2C). In practice, PEF trains that
were used to study electrosensitization effects (up to 300 pulses)
did not raise the temperature to potentially damaging levels.
Cell Culture and PEF Cytotoxicity in 3D Cultures
Three-dimensional cultures in agarose were described in detail
previously.37 Briefly, the bottom of a 35-mm dish was coated
with 3 mL of 2.5% low-gelling-temperature agarose (Sigma-
Aldrich, St Louis, Missouri) in the growth medium. Cells were
resuspended at 5  106 cell/mL in 1% agarose in the growth
medium, and 1.5 mL of this suspension was pored over the
presolidified 2.5% agarose base layer. The samples were incu-
bated at 4C for 5 minutes to speed up agarose jellification thus
avoiding cell sedimentation, covered with 0.5 mL of media, and
kept in the incubator for 30 minutes before PEF treatment.
The agarose cultures were analyzed 2 hours after exposure.
Dead cells were stained using 4 mg/mL of propidium iodide
(PI; Sigma-Aldrich) in phosphate-buffered saline (PBS). Thirty
minutes before the analysis, the growth mediumwas replaced with
1 mL of PI solution. Images of the ablation zone were acquired
using an Olympus SZX16 fluorescence stereo microscope (Olym-
pus America, Hamden, Connecticut) equipped with a Hamamatsu
C9100 EM-CCD camera using a 0.9, 0.44 NA objective.
Images were analyzed with MetaMorph version 7.5.2 soft-
ware (Molecular Devices, Foster City, California). Propidium
(Pr) signal was quantified in the center of the gap between the
electrodes within a region of 1 mm2 with almost uniform electric
field (Figure 2A). For each image, the fluorescence intensity of
the exposed area was corrected for the background fluorescence.
Murine Tumor Model
Seven- to 8-week-old DBA/2 J female mice (Jackson Laboratory,
Bar Harbor, Maine) were anesthetized by inhalation of 3% iso-
flurane and inoculated subcutaneously in the left dorsolateral
Figure 2. The electric field distribution (A) and temperature measurements (B and C) in 3-dimensional (3D) cell cultures. The electric field
distribution in the plane perpendicular to the needle electrodes (white circles) and 3.8 mm above the bottom of the Petri dish (left) and within the
1 mm2 region of interest (ROI) used for the quantification of the propidium (Pr) fluorescence (right). Note that the 2 maps have different color
scales. For 100 V applied between the electrodes, the mean electric field in the ROI was 0.082 kV/cm with 1.2% variation. B, The fiber optic
probe, used to measure the temperature, placed in the center of the gap between the electrodes. C, Temperature rise measured after 300, 300 ns
pulses (20 Hz) delivered at the indicated voltages.
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flank region with 1 106 KLN 205 cells in 50 mL of PBS. Mice
were housed in individually ventilated cages in groups of 5 under
pathogen-free conditions. Tumors were allowed to grow to a
volume of approximately 35 to 45 mm3 before PEF treatment.
Tumor growth was measured at 24 hours posttreatment and twice
weekly using a digital caliper, and volumes (v) were calculated
using a standard formula v ¼ ab2p/6, where a is the longest
diameter, and b is the next longest diameter perpendicular to a.
Mice were humanely euthanized when the tumor reached 800
mm3. Tumors were considered eliminated when no recurrence
was detected within 100 days after treatment. Tumor doubling
time (DT) was calculated using the Schwartz formula.48
This experiment protocol was approved by the Old Domin-
ion University Institutional Animal Care and Use Committee
(permit number: 15-009).
Statistical Analysis
Data are presented as mean + standard error for n independent
experiments. Statistical analyses were performed using a
2-tailed t test where P < .05 was considered statistically
significant. Statistical calculations, including data fits, and data
plotting were accomplished using Grapher 11 (Golden Software,
Golden, Colorado).
Results
Quantification of the Electrosensitization Phenomenon
In Vitro in 3D Agarose Cultures
In our previous publications, the electrosensitization phenom-
enon has been investigated by using exposure system with 1 mm
distance between the PEF-delivering electrodes (ie, 1-mm gap
cuvettes or a 1-mm gap 2-needle probe).28,35,37 However,
because our in vivo model envisages the treatment of tumors
of about 5 mm in diameter, here, we studied the effect of dose
fractionation on the size of ablation zone generated in a 3D
agarose culture by applying a voltage across a 6.5-mm gap.
As a first step, we established the PEF conditions needed to
kill in 2 hours 100% of cells between the PEF-delivering elec-
trodes. For consistency with our previous research,37 we used
pulses of 300 ns duration. The effect of increasing number of
pulses 300 ns (6.4 V, 20 Hz) on KLN 205 cells embedded in 1%
agarose was visualized by the Pr fluorescence in the lethally
damaged cells. Figure 3 shows that significant cell killing
started after 200 or more pulses. To quantify this effect, we
measured the Pr fluorescence intensity in a region of 1 mm2 in
the center of the gap between the electrodes where cells expe-
rienced nearly uniform electric field (Figures 3A and 4). Pro-
pidium fluorescence intensity reached a plateau at 400 to 800
pulses indicating that at these doses, 100% of the cells in the
quantified area were killed. Therefore, in the subsequent
experiments, a parallel control exposure of 600 pulses was used
as a reference point for Pr fluorescence that corresponds to
100% cell death.
To investigate the electrosensitization phenomenon, 300
pulses (300 ns, 20 Hz) were delivered either as a single train
or as 2 trains with a 2-minute interval (also referred to as single-
and split-dose treatments below), and the voltage applied was
varied from 4.4 to 6.4 kV. Figure 4A shows for a representative
experiment that fractionated treatments produced larger
Pr-positive region. Maximum sensitization effect was seen at
4.4 kV (3.6 kV/cm in the center between the electrodes) where
Figure 3. Analysis of the cytotoxic effect of 300 ns, 6.4 kV pulses in KLN 205 cells embedded in agarose. A, The ablation area between and
around the 6.5-mm gap pulsed electric field (PEF)–delivering electrodes (arrows) was visualized by propidium (Pr) uptake by dead cells. Images
were taken 2 hours after exposure to the indicated number of pulses. Scale bar: 1 mm. B, Quantification of the cytotoxic effect by the mean
intensity of Pr fluorescence (as measured within the region of interest shown in (A). Mean + standard error (SE), n¼ 3. Note signal saturation at
400 to 800 pulses, which indicates killing of 100% of cells within the studied region.
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the Pr signal increased 3 times and lethality increased from
12%-16% to 41%-46% (Figure 4B). At the next higher ampli-
tude (5.4 kV), fractionated doses were significantly more effi-
cient as well. However, at 6.4 kV where the single dose already
killed 80% of the cells, approaching the fluorescence saturation
point, splitting the PEF train in fractions had no additional
effect.
Overall, in these in vitro experiments, we established the
conditions necessary to achieve efficient sensitization effect
using a large gap PEF-delivering probe.
Electrosensitization Assists Tumor Ablation by nsPEF
In Vivo
The lethal electric field threshold for cells in medium may
considerably differ from that of tumors in vivo.49,50 Hence,
the PEF conditions to see electrosensitization in vivo needed
to be tested in preliminary experiments. Our in vitro data
showed that splitting in fractions a PEF dose that kills 20%
to 50% of the cells, causes maximum electrosensitization
effect. To identify the PEF dose that matches these conditions
in vivo, we investigated the antitumor efficacy of 300 ns
pulses over a range of electric field amplitudes. At 24-hour
posttreatment, 300, 300-ns pulses (20 Hz) at 6.4 kV caused
50% tumor reduction, and therefore this PEF dose was
selected to study the electrosensitization phenomenon in vivo
(data not shown).
At the time of treatment, tumors were on average 40.2, 41.2,
and 39.2 mm3 for sham exposure, single-dose, and split-dose
groups, respectively (Table 1). Tumor size was assessed 24
hours after the treatment and then monitored twice weekly for
3 weeks. At 24 hours after the treatment, split-dose protocols
(150þ 150 pulses) with intertrain interval of 2 minutes, caused
a 4- and 2-fold tumor volume reduction as compared to sham
and single-dose exposure controls, respectively (Figure 5A). In
the split-dose group, 43% of the animals exceeded the 75%
level of tumor volume reduction, whereas only 12% of
single-dose treated animals achieved a similar ablation level
(Figure 5B). The difference between single- and split- dose
treatments remained statistically significant for at least 1 week
after the treatment (Figure 5A). No differences in tumor DT
were observed between the different experimental groups sug-
gesting that the tested nsPEF did not trigger any tumor growth
inhibition besides their lethal effect at the time of treatment
(Figure 5C). Finally, none of the animals were cured with the
single-dose protocol, whereas 1 split-dose treatment resulted in
complete tumor regression with no recurrence (tumor-free ani-
mal for 100 days).
Discussion
In this study, we show, for the first time, that split-dose nsPEF
treatments engaging electrosensitization facilitate tumor
Table 1. Average Tumor Size on the Day of PEF Treatment and the
Number of Animals in the Experimental Groups.
Groups Sham 300 Pulses
150 þ 150
Pulses
Average tumor size at the time
of treatment, mm3
40.2 + 3.7 41.2 + 3 39.2 + 2.6
Number of animals per group 15 17 14
Abbreviation: PEF, pulsed electric field.
Figure 4. Electrosensitization efficiency at different applied voltages when using a pulsed electric field (PEF)–delivering probe with 6.5 mm gap
between the electrodes. KLN 205 cells seeded in 1% agarose were exposed to either a single train of 300 pulses (300 ns, 20 Hz) or 2 trains of 150
pulses each with a 2-minute interval. The pulse amplitude was varied from 4.4 to 6.4 kV. A, Each sample at 4.4 kV, a representative propidium
(Pr) fluorescence image. The arrows identify the nanosecond pulsed electric field (nsPEF) delivering electrodes. Scale bar: 1 mm. The
quantification in (B) shows the Pr uptake (left Y-axis) and the percentage of cell death (right Y-axis) measured within the region of interest (white
square) shown in (A). Mean + standard error (SE), n ¼ 5 to 6. *P < .01 and **P < .001.
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destruction in vivo as well as in vitro. Despite delivering equiv-
alent doses, splitting a PEF train in 2 fractions with a 2-minute
interval caused a 2-fold tumor volume reduction compared to
single-train treatments. All mice treated with the split-dose
treatment experienced a significant reduction in tumor volume,
and this difference remained statistically significant for a week.
However, with the PEF dose used in the study (300, 300-ns
pulses, 20 Hz at 6.4 kV), engaging electrosensitization did not
cause persistent tumor regression. Maximum electrosensitiza-
tion effect may develop within a certain range of pulse ampli-
tudes, durations, frequencies, number of pulses, and trains. It
remains to be fully established how various PEF parameters
affect the development of electrosensitization. In this study,
because the needles penetrated the body of the mouse, the
range of PEF doses that could be tested was limited by the risk
of harming internal organs. For instance, 6.4 kV was the high-
est PEF amplitude that was also well tolerated by the animals.
We therefore believe that the results of this pilot study can
be further improved by a careful design of the PEF-
delivering electrodes thus allowing to optimize the PEF
parameters in vivo.
We previously reported that the time interval between trains
affects cell killing by electrosensitization. In KLN 205
embedded in 3D agarose, dose fractionation enhanced Pr
uptake when the intertrain interval reached 100 seconds.37
However, the time course of electrosensitization in vitro and
in vivo in tumors may differ. In this study, we used 2-minute
intervals that might have not been optimal to cause maximum
facilitation of cell killing by engaging electrosensitization.
Future work will focus on the optimization of the intertrain
interval to fully characterize the potential of electrosensitiza-
tion for tumor ablation.
Other groups have introduced time intervals between trains
in their PEF protocols but with the aim of either allow for heat
dissipation51 or to recharge the pulse generator.52,53 We are
aware of only 1 study that investigated how intertrain intervals
affect IRE efficiency.54 Indeed, by splitting fifty-one 50-ms
pulses in 3 trains of 17 pulses each with 30-second intervals,
Jiang et al found increased tumor destruction.54 In reality, these
authors exploit split-dose protocols without being aware of the
electrosensitization phenomenon. Moreover, they did not use
this term themselves.
A critical question that needs to be addressed is what phy-
siological mechanisms are responsible for electrosensitization.
One possible mechanism of electrosensitization may involve
the influx of calcium (Ca2þ) through the nanopores. Ca2þ
changes impact nearly every aspect of cellular life, and there-
fore its intracellular concentration and localization are highly
regulated.55 Split-dose treatments prolong the time intervals
when the internal Ca2þ is elevated, and this loss of homeostasis
Figure 5. In vivo split-dose treatments engaging electrosensitization increase the antitumor effectiveness of nsPEF. A, Tumor growth curves in
sham exposure, single-dose 300 pulses (300 ns, 6.4 kV, 20 Hz), and split-dose 150þ 150 pulses with 2-minute interval experimental groups. For
each animal, the data were normalized to the tumor volume measured immediately before treatment. B, The tumor reduction frequency
histogram at 24 hours after the treatment. C, The tumor doubling time. Mean + standard error (SE), n ¼ 15, 17, and 14 for sham, split- and
single-dose groups, respectively. *P < .05 for the difference between single- and split-dose groups.
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may cause cell death through both necrosis and apoptosis. The
prolonged PEF treatment may also aggravate the adenosine
triphosphate (ATP) demand to sustain membrane repair and
ion pumps activated to restore ion gradients.56 Therefore, one
can speculate that a prolonged high demand for ATP combined
with the ATP loss through pores could be a factor responsible
for electrosensitization.
Future search for mechanisms responsible for electrosen-
sitization should also focus on how PEF “prime” the cells
making them hypersensitive to electroporation. The first train
of pulses may increase the level of reactive oxygen species
(ROS).57,58 A recent study reported that oxidative damage to
the membrane increases its susceptibility to electroporation.59
Hence, the PEF-induced ROS production may increase the
cell membrane sensitivity to subsequent treatments. Electro-
sensitization may be explained by the PEF-induced colloid
osmotic cell swelling phenomenon. Permeabilization of cells
leads to water uptake and cell swelling due to the so-called
colloid osmotic mechanism.15 The increase of cell diameter
translates into a higher PEF-induced transmembrane potential
and therefore increases electroporation.60 Swelling takes tens
of second, which may explain the time dynamic of the elec-
trosensitization onset.
As of today, none of these mechanisms have been estab-
lished as a cause of electrosensitization. We expect that a better
understanding of the electrosensitization phenomenon will help
to develop more effective PEF treatments.
The results of this in vivo study warrant further exploration
of electrosensitization as a facilitating factor for tumor ablation
by IRE. Contrary to other approaches used in combination with
PEF, engaging electrosensitization does not require chemother-
apeutic drugs or cytotoxic agents, and it can be easily inte-
grated in existing IRE protocols. Electrosensitization may
allow to reduce the pulse amplitude or to enlarge the distance
between the PEF-delivering electrodes without losing the abla-
tion efficiency. More research is needed to establish the opti-
mal PEF conditions as well as to reveal the mechanisms
underlying electrosensitization.
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